Health Catalyst Q2 adjusted EBITDA beats estimates

Health Catalyst

06/08/2026 21:30

Overview
US healthcare intelligence firm's Q2 revenue fell 13% yr/yr to $70.5 mln
Adjusted EBITDA for Q2 beat analyst expectations
Company completed Vitalware divestiture and fully repaid credit facility debt

Outlook
Health Catalyst expects Q3 2026 revenue of $55 mln to $56 mln
Company sees Q3 2026 adjusted EBITDA of $0 to $0.5 mln
Health Catalyst projects full-year 2026 revenue of $246 mln to $249 mln
Company expects full-year 2026 adjusted EBITDA of $18 mln to $18.5 mln

Result Drivers
VITALWARE DIVESTITURE - Co said it completed the Vitalware divestiture and fully repaid its credit facility debt, improving balance sheet flexibility
RESTRUCTURING COSTS - Co incurred restructuring costs related to workforce reductions and board changes during the qtr
GOODWILL IMPAIRMENT - Co recognized goodwill impairment in the technology reporting unit as a result of impairment indicators and quantitative tests

Company press release: ID:nGNX6PhVxS

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
 
$70.49 mln
 
Q2 Net Loss
 
$40.54 mln
 
Q2 Adjusted EBITDA
Beat
$9.92 mln
$9.41 mln (6 Analysts)
Q2 Adjusted Gross Margin
 
51%
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the software peer group is "buy"
Wall Street's median 12-month price target for Health Catalyst, Inc. is $2.25, about 5.9% below its August 5 closing price of $2.39
The stock recently traded at 34 times the next 12-month earnings vs. a P/E of 9 three months ago

Reuters Recommended Reads
Aug 4 - Amwell Q2 revenue falls, co lifts low end of FY guidance 
Aug 6 - CareCloud Q2 revenue rises 16%, slightly beats estimates
Aug 5 - Solventum to hive off healthcare software business, raises profit forecast

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)